The same year, Foligne et al. demonstrated that BL23 induced an immune reaction with dominance of anti-inflammatory IL-10 over pro-inflammatory IL-12 in human peripheral blood mononuclear cells and reduced the symptoms of murine 2,4,6-trinitrobenzenesulfonic acid (TNBS) colitis (74). The gene discussed is IL10; the disease is colitis.